Literature DB >> 18579928

The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec.

Marie Tournier1, Yola Moride, Mark Lesk, Thierry Ducruet, Sophie Rochon.   

Abstract

BACKGROUND: With the aging of the population, age-related macular degeneration (AMD) is becoming a public health concern. Few studies have assessed its consequences on morbidity and mortality, and the findings are conflicting.
OBJECTIVES: To assess the risk of depression, fracture, institutionalization, and death among elderly patients with suspected exudative AMD and the impact of the depletion of susceptibles effect in a burden-of-illness study.
METHODS: A population-based retrospective cohort study was conducted in the community-dwelling elderly population of Quebec. The cohort was assembled through the Quebec medical claims database (RAMQ). Among patients age 65 and older with a claim involving a diagnosis of AMD over the years 2000 to 2004, those with suspected exudative AMD (n=2,071) were retained, using fluorescein angiography as a marker. The reference cohort consisted of a sample of 16,932 elderly without a claim involving AMD or visual impairment.
RESULTS: Suspected exudative AMD was associated with an increased risk of depression (hazard ratio HR=1.3, 95%CI 1.18-1.43) and fracture (HR=1.19, 95%CI 1.03-1.37), but a decreased risk of institutionalization (HR=0.55, 95%CI 0.42-0.71) and death (HR=0.68, 95%CI 0.59-0.78). After adjustment for the incident/prevalent status of the AMD, the association between suspected exudative AMD and institutionalization was no longer statistically significant (HR=0.75, 95%CI 0.5-1.12).
CONCLUSIONS: These findings enhance the need to detect visual loss and to consider patients' ability to adapt to AMD, to maintain their quality of life. Failure to account for duration of illness and the depletion of susceptibles effect may bias results of burden-of-illness studies.

Entities:  

Mesh:

Year:  2008        PMID: 18579928

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  6 in total

1.  Predictors of Cigarette Smoking Initiation in Early, Middle, and Late Adolescence.

Authors:  Jennifer O'Loughlin; Erin K O'Loughlin; Robert J Wellman; Marie-Pierre Sylvestre; Erika N Dugas; Miguel Chagnon; Hartley Dutczak; Johanne Laguë; Jennifer J McGrath
Journal:  J Adolesc Health       Date:  2017-03-18       Impact factor: 5.012

2.  Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.

Authors:  Ben Schöttker; Christian Herder; Dietrich Rothenbacher; Laura Perna; Heiko Müller; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2013-01-26       Impact factor: 8.082

3.  Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults.

Authors:  Carolin Gellert; Ben Schöttker; Heiko Müller; Bernd Holleczek; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2013-02-09       Impact factor: 8.082

4.  Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.

Authors:  Hedi Schelleman; Warren B Bilker; Colleen M Brensinger; Fei Wan; Yu-Xiao Yang; Sean Hennessy
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965

5.  Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.

Authors:  Hedi Schelleman; Colleen M Brensinger; Warren B Bilker; Sean Hennessy
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

6.  Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium.

Authors:  Ute Mons; Aysel Müezzinler; Carolin Gellert; Ben Schöttker; Christian C Abnet; Martin Bobak; Lisette de Groot; Neal D Freedman; Eugène Jansen; Frank Kee; Daan Kromhout; Kari Kuulasmaa; Tiina Laatikainen; Mark G O'Doherty; Bas Bueno-de-Mesquita; Philippos Orfanos; Annette Peters; Yvonne T van der Schouw; Tom Wilsgaard; Alicja Wolk; Antonia Trichopoulou; Paolo Boffetta; Hermann Brenner
Journal:  BMJ       Date:  2015-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.